INDUSTRY ANALYSIS AND

DESK RESEARCH
NAME : RUDRA RAJENDRA MARAL
ROLL NO.: 20210101094
INSTITUTE : SIMMC-A (MBA)
TOPIC : PHARMACEUTICALS
 CONTENT

• i) Sector size in India • xii) Government policies related to the sector, growth targets, outlay in budgets.

• ii) Sector size across the globe • xiii) Taxes and duties related to the sector / products / services

• iii) Sector size – state wise in India • xiv) International situation and norms regarding the sector.

• iv) Growth rates & trends for last 5 years. History, Introduction and evolution of the • xv) Import and export trends
sector. Date
• xvi) Top 5 companies worldwide in the sector
• wise / Chronological events and milestones
• xvii) Share prices of top 10 companies in the sector, indicators and analysis
• v) Factors affecting growth, key drivers affecting growth
• xviii) News on the sector – all articles appeared in last 1 year from Economic Times
• vi) Number of companies in the sector. Top 5 companies and their details. Company profile
of the • xix) Associations and organizations related to sectors

• leader and next company • xx) FDI and investments in the sector

• vii) Segments within the sector. Segment wise growth and statistics • xxi) Status of allied industry related to the sector

• viii) Indicators, ratios, statistics, analysis • xxii) Mergers and acquisitions in the sector

• ix) Employment statistics • xxiii) Customer needs in the sector

• x) Technology status and updates in the sector • xxiv) Compile advertisements of companies in the sector

• xi) Outlook / expected growth in the sector • xxv) Patents and IPR statistics in the sector
Pharmaceuticals Sector size in India
India's domestic pharmaceutical market is at US$ 42 billion (Rs
3355758000000)  in 2021 and likely to reach US$ 65 billion by 2024
and further expand to reach ~US$ 120-130 billion by 2030.

Pharmaceuticals Sector size across the Globe

The global pharmaceutical manufacturing market size was estimated at

USD 405.52 billion in 2020 and is expected to reach USD 486.62 billion in
2021.
HISTORY In BRIEF
Indian pharmaceutical history began from Gupta period which was
existed from approximately 320 to 550 CE where people were
dependent only on indigenous form of medicine before British rule.
In India Allopathic medication was started in British rule, but
production of such medicines was not in the country.
In 1901 Acharya P C Ray started first Indian Pharmaceutical Industry,
Bangal Chemical in Calcutta.
The government started to encourage the growth of drug manufacturing
by Indian
GROWTH

The Indian pharma industry has been growing at a compounded

annual growth rate (CAGR) of more than 15% over the last five
years and has significant growth opportunities
Adopt new business models and think of innovative ideas to
service their evolving customers faster and better.
Pharma companies will continue to grow both organically and
inorganically through alliances and partnerships. They will
continue to focus on improving operational efficiency and
productivity. 
TOP 5 COMPANIES
SEGMENTS WITHIN THE
SECTORS
Employment statistics
TECHNOLOGY STATUS
Here are the top eight pharma healthtech
trends that will shake up the industry:

1.Artificial Intelligence
2.Wearable Tech Integration
3.Data Management & Analytics
4.Single-Use Processes
5.Precision Medicine
6.Bioprinting
7.“In Silico” Testing
8.Real-World Data
 Outlay in budgets.
Certain amendments in the Union Budget which relevance to the pharmaceutical industry are:

•Introduction of National Digital Health Ecosystem, an open platform consisting of digital registries of health
providers and health facilities, unique health identity, consent framework and universal access to health facilities
•Launch of National Tele Mental Health Programme with 23 tele-mental health centres of excellence for better access
to quality mental health counselling and care services.
•Extending the time limit for commencement of manufacturing or production to avail concessional 15 percent tax
regime for new manufacturing facilities to March 31, 2024.
•Non-taxability in recipient’s hands of the sum received to be spent on COVID-19 related illness and receipt of funds
by a family from an employer or any person on death of individual subject to conditions prescribed.
•Provide sunrise opportunities to pharmaceutical companies to assist sustainable development at scale. For R&D in
these sunrise opportunities, in addition to efforts of collaboration among academia, industry and public institutions,
government contribution will be provided.
GLOBAL Guidelines: Norms and
Standards for Pharmaceuticals
WHO norms and standards for pharmaceuticals
guidelines which are grouped into:
(1) development
(2) production
(3) distribution
(4) inspection
(5) quality control
(6) regulatory standards and
(7) specific texts for prequalification of medicines
Taxes and duties related to the
pharmaceutical sector
News on the pharmaceutical sector
economic times
Generic drug companies in no hurry to launch new Covid pr
oducts
BDR Pharmaceuticals, a Mumbai-based active pharmaceutical
ingredient (API) manufacturing company, has developed the
API of antiviral pill Paxlovid and can manufacture the drug but
it has decided to wait and watch, Shah said. "We will see if
there is any need in the country to launch it," he told ET. "At
present, cases are mild and are recovering with the conventional
treatment.
News on the pharmaceutical
sector economic times
As Covid sales spike ebbs, what lies ahead for pharma comp
anies?
Indian pharmaceutical market flattened after the pandemic led
to a massive upsurge in demand for drugs. The industry saw a
rise in sales during the Covid spike but that settled down as the
number of coronavirus cases came down, except for Q1FY2022,
where the second Covid wave was dominant. This resulted in a
dip in the top line of pharma companies in the successive
quarters.
News on the pharmaceutical
sector economic times
Indian pharma can't afford to miss governance bus amid gr
owth focus
Regulatory clampdowns and legislative changes are likely to
expose the governance fault lines of the companies in the sector.
Investors in the sector need to be cognisant of these emerging
risk factors.
News on the pharmaceutical sector
economic times
Indian pharma industry may rebound to 8-11 pc growth rate
; inflationary pressures, regulatory norms key risks:
Alkem
On the outlook for the domestic business, Alkem Laboratories
said, "With easing out of COVID-19 restrictions, resumption of
travel, normalisation of supply chain and manufacturing
activities, reopening of schools and offices, and a resumption of
deferred elective medical treatments, the Indian pharmaceutical
industry is expected to rebound to a normalised growth rate of
8-11 per cent."
News on the pharmaceutical
sector economic times
Exempt cheap drugs from price control, say Indian Pharma
ceutical Alliance
Mehta batted for a market friendly pricing structure which will
help in accessibility of medicines to the patients and increase
investment in research and overall export thrust in global
market.
News on the pharmaceutical
sector economic times
Sun Pharma to expand field force in India by 10 pc this fisca
l
"The field force expansion done in FY21 has met with good
success and considering the current market conditions, we will
be undertaking a further expansion of about 10 per cent for our
field force in FY23, driven by the twin objectives of brand
focus and geographical expansion," Sun Pharmaceutical
Industries CEO (India Business) Kirti Ganorkar said in an
analyst call.
News on the pharmaceutical
sector economic times
Pharma companies are now busy adding capacities and seei
ng a surge in demand for non-Covid drugs
Indian drug manufacturers launch 300-350 new brands (mostly
repurposed or combinations of two earlier drugs) every year.
This had slowed down in the initial months of Covid-19 as most
companies were trying to assess the situation. But with Covid
cases falling, new launches are almost back to preCovid levels,
say drug wholesalers
News on the pharmaceutical
sector economic times
Pharma department suggests allocation of funds by institute
s to promote startups
​In its common guidelines on pharmaceutical innovation and
entrepreneurship for academic institutions, the Department of
Pharmaceuticals (DoP) also said that institutes may take a fixed
percentage of (2 per cent to 9.5 per cent) equity in startup/spin-
off companies in return for the services and facilities they
provide
News on the pharmaceutical
sector economic times
Pharma industry must focus on generic, better link between input and ou
tput: Piyush Goyal
In this situation, the minister said, "it's extremely important that we focus not
only on our strengths in the generic sector but also ensure our backward and
forward linkages."
Organization related to sector:
Mergers and Acquisitions
 Customers
In pharma, a customer can be a patient, physician, payer, or provider. Companies that
proactively engage the customer, whoever that may be, will be able to navigate the
rapidly changing environment
Examples of Advertisings
THANK YOU